GlassScriptPhysician profile
Monika Debkowska
NPI 1528445285
$1,983.88
in general payments reported to CMS, 2019-2025
12 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what 77% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $82.61 · 2022: $524 · 2023: $16.43 · 2024: $32.83 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $912 · Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $912.12 |
| Food and Beverage | $465.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $999.90 | 2025 | |
| Stryker Corporation | $341.34 | 2022-2025 | Aequalis Perform Reversed |
| Seapearl East, INC | $196.48 | 2025 | |
| Acumed LLC | $179.47 | 2022 | |
| Endo Pharmaceuticals INC. | $82.61 | 2021 | |
| Collegium Pharmaceutical, INC. | $52.13 | 2024-2025 | Belbuca |
| Smith+Nephew, INC. | $39.90 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Kerecis Limited | $21.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $20.25 | 2022 | |
| Amgen INC. | $17.12 | 2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $16.43 | 2023 | Seglentis |
| Pacira Pharmaceuticals Incorporated | $16.28 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monika Debkowska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.